Enhanced oral bioavailability of insulin-loaded solid lipid nanoparticles: pharmacokinetic bioavailability of insulin-loaded solid lipid nanoparticles in diabetic rats
- PMID: 26017100
- DOI: 10.3109/10717544.2015.1039666
Enhanced oral bioavailability of insulin-loaded solid lipid nanoparticles: pharmacokinetic bioavailability of insulin-loaded solid lipid nanoparticles in diabetic rats
Abstract
Objective: Insulin is a hormone used in the treatment of diabetes mellitus. Multiple injections of insulin every day may causes pain, allergic reactions at injection site, which lead to low patient compliance. The aim of this work was to develop and evaluate an efficient solid lipid nanoparticle (SLN) carrier for oral delivery of insulin.
Methods: SLNs were prepared by double emulsion solvent evaporation (w/o/w) technique, employing glyceryltrimyristate (Dynasan 114) as lipid phase and soy lecithin and polyvinyl alcohol as primary and secondary emulsifier, respectively, and evaluated in vitro for particle size, polydispersity index (PDI) and drug entrapment.
Results: Among the eight different developed formulae (F1-F8), F7 showed an average particle size (99 nm), PDI (0.021), high entrapment of drug (56.5%). The optimized formulation (F7) was further evaluated by FT-IR, DSC, XRD, in vitro release, permeation, stability, bioavailability and pharmacological studies. Insulin-loaded SLNs showed better protection from gastrointestinal environment as evident from the relative bioavailability, which was enhanced five times as compared to the insulin solution. A significant enhancement of relative bioavailability of insulin was observed, i.e. approximately five times of pure insulin solution when loaded in SLN (8.26% versus 1.7% only).
Keywords: Characterization; insulin; pharmacokinetic; solid lipid nanoparticles; stability.
Similar articles
-
Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.Drug Deliv. 2016;23(2):395-404. doi: 10.3109/10717544.2014.914986. Epub 2014 May 28. Drug Deliv. 2016. PMID: 24865287
-
Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization.AAPS PharmSciTech. 2018 May;19(4):1712-1719. doi: 10.1208/s12249-018-0987-2. Epub 2018 Mar 12. AAPS PharmSciTech. 2018. PMID: 29532427
-
Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.Artif Cells Nanomed Biotechnol. 2018;46(sup2):616-625. doi: 10.1080/21691401.2018.1465068. Epub 2018 Apr 24. Artif Cells Nanomed Biotechnol. 2018. PMID: 29688077
-
Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment.J Control Release. 2017 Oct 28;264:247-275. doi: 10.1016/j.jconrel.2017.09.003. Epub 2017 Sep 5. J Control Release. 2017. PMID: 28887133 Review.
-
Solid lipid nanoparticles as oral delivery systems of phenolic compounds: Overcoming pharmacokinetic limitations for nutraceutical applications.Crit Rev Food Sci Nutr. 2017 Jun 13;57(9):1863-1873. doi: 10.1080/10408398.2015.1031337. Crit Rev Food Sci Nutr. 2017. PMID: 26192708 Review.
Cited by
-
The Science of Solid Lipid Nanoparticles: From Fundamentals to Applications.Cureus. 2024 Sep 6;16(9):e68807. doi: 10.7759/cureus.68807. eCollection 2024 Sep. Cureus. 2024. PMID: 39376878 Free PMC article. Review.
-
Formation of multimeric antibodies for self-delivery of active monomers.Drug Deliv. 2017 Nov;24(1):199-208. doi: 10.1080/10717544.2016.1242179. Drug Deliv. 2017. PMID: 28156181 Free PMC article.
-
Polymeric biocompatible iron oxide nanoparticles labeled with peptides for imaging in ovarian cancer.Biosci Rep. 2022 Feb 25;42(2):BSR20212622. doi: 10.1042/BSR20212622. Biosci Rep. 2022. PMID: 35103283 Free PMC article.
-
Design and optimization various formulations of PEGylated niosomal nanoparticles loaded with phytochemical agents: potential anti-cancer effects against human lung cancer cells.Pharmacol Rep. 2023 Apr;75(2):442-455. doi: 10.1007/s43440-023-00462-8. Epub 2023 Mar 1. Pharmacol Rep. 2023. PMID: 36859742
-
Review of recently used techniques and materials to improve the efficiency of orally administered proteins/peptides.Daru. 2020 Jun;28(1):403-416. doi: 10.1007/s40199-019-00316-w. Epub 2019 Dec 6. Daru. 2020. PMID: 31811628 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous